Use of H3K9me3 modulation for enhancing cognitive function

Use of H3K9me3 modulation for enhancing cognitive function and treating anxiety related disorders is presented. A composition is administered to the subject comprising a therapeutically effective amount of a SUV39H1 inhibitor comprising analogs of ETP69. The therapeutically effective amount is effec...

Full description

Saved in:
Bibliographic Details
Main Authors Cotman, Carl W, Snigdha, Shikha, Overman, Larry E
Format Patent
LanguageEnglish
Published 01.12.2020
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Use of H3K9me3 modulation for enhancing cognitive function and treating anxiety related disorders is presented. A composition is administered to the subject comprising a therapeutically effective amount of a SUV39H1 inhibitor comprising analogs of ETP69. The therapeutically effective amount is effective in treating cognitive dysfunction in aging and age-related disorders.
Bibliography:Application Number: US201916354996